Patents by Inventor Kengo Usui

Kengo Usui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190160466
    Abstract: The present invention provides a tool that can analyze a target in a sample with simple operations and can be downsized, and an analysis method using the same. The analysis cell of the present invention includes: a main substrate: a sample inlet cover member; and a gas outlet cover member. The main substrate includes a flow path, an inlet for a sample, and a gas outlet, and the inlet and the gas outlet communicate with an outside. The inlet communicates with an upstream end portion of the flow path and the gas outlet communicates with a downstream end portion of the flow path. The flow path has a shape that expands from an upstream side toward a downstream side of the flow path. The sample inlet cover member is a liquid-tight member and can be fixed to the inlet when the sample inlet cover member is in use. The gas outlet cover member is a liquid-tight and gas-permeable member and can be fixed to the gas outlet when the gas outlet cover member is in use.
    Type: Application
    Filed: July 25, 2017
    Publication date: May 30, 2019
    Inventors: Yutaka YAMAGATA, Hiroyoshi AOKI, Kengo USUI, Yuki TANAKA, Norihiro MATSUYAMA, Kanji MITA
  • Patent number: 10066264
    Abstract: The present invention is to provide a method for analyzing a target nucleic acid, by which the target nucleic acid can be analyzed rapidly and easily. In order to achieve the above object, the present invention provides a method for analyzing a target nucleic acid in a sample, including the step of: analyzing the target nucleic acid in the sample by bringing the sample into contact with a label and with a primer or probe that can hybridize to the target nucleic acid. The primer or probe is immobilized on a solid phase. The label does not emit light when the primer or probe does not hybridize to the target nucleic acid, whereas the label emits light when the primer or probe has hybridized to the target nucleic acid. The analysis is carried out by detecting the light emitted from the label.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: September 4, 2018
    Assignee: KABUSHIKI KAISHA DNAFORM
    Inventors: Yoshihide Hayashizaki, Masayoshi Itoh, Takahiro Arakawa, Kengo Usui, Sotaro Uemura, Yasumasa Mitani
  • Patent number: 9586987
    Abstract: The present invention provides a primer set including primers that can be designed easily, with which an amplification distance can be shortened. Provided is a primer set for use in a method for isothermally amplifying a target nucleic acid sequence 4. The primer set includes a first primer 1F and a second primer 1R. The first primer 1F includes, on the 3? side thereof, a sequence (A?) that can hybridize to a sequence (A) on the 3? side of the target nucleic acid sequence. The second primer 1R includes, on the 3? side thereof, a sequence (B?) that can hybridize to a sequence (B) on the 3? side of either a strand extended from the first primer or a complementary strand of the target nucleic acid sequence 4. The first primer 1F and the second primer 1R include, on the 5? sides thereof, sequences (C) that are substantially identical to each other.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: March 7, 2017
    Assignee: Kabushiki Kaisha DNAFORM
    Inventors: Yoshihide Hayashizaki, Yasumasa Kimura, Kengo Usui, Yuki Tanaka, Yuki Kawai
  • Patent number: 9518901
    Abstract: The present invention is to provide a pretreatment method that allows RNA to be detected promptly and simply. RNA degradation activity due to lactoferrin present in the human rhinal mucosa is inhibited, for example, by adding iron ion and carbonate ion to a biological sample that contains the human rhinal mucosa. With the pretreated biological sample, an RNA virus gene can be amplified by a reverse transcriptase. Iron ion and carbonate ion can also inhibit reverse transcriptase inhibition due to lysozyme C contained in the human rhinal mucosa. Further, it is preferable to remove the envelope of the RNA virus by adding SDS to the biological sample that contains the human rhinal mucosa.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: December 13, 2016
    Assignee: KABUSHIKI KAISHA DNAFORM
    Inventors: Yoshihide Hayashizaki, Kengo Usui, Saori Goda, Kazuhito Nomura, Yuki Kawai
  • Publication number: 20150152496
    Abstract: The present invention is to provide a method for analyzing a target nucleic acid, by which the target nucleic acid can be analyzed rapidly and easily. In order to achieve the above object, the present invention provides a method for analyzing a target nucleic acid in a sample, including the step of: analyzing the target nucleic acid in the sample by bringing the sample into contact with a label and with a primer or probe that can hybridize to the target nucleic acid. The primer or probe is immobilized on a solid phase. The label does not emit light when the primer or probe does not hybridize to the target nucleic acid, whereas the label emits light when the primer or probe has hybridized to the target nucleic acid. The analysis is carried out by detecting the light emitted from the label.
    Type: Application
    Filed: August 29, 2013
    Publication date: June 4, 2015
    Inventors: Yoshihide Hayashizaki, Masayoshi Itoh, Takahiro Arakawa, Kengo Usui, Sotaro Uemura, Yasumasa Mitani
  • Publication number: 20140295447
    Abstract: The present invention provides a primer set including primers that can be designed easily, with which an amplification distance can be shortened. Provided is a primer set for use in a method for isothermally amplifying a target nucleic acid sequence 4. The primer set includes a first primer 1F and a second primer 1R. The first primer 1F includes, on the 3? side thereof, a sequence (A?) that can hybridize to a sequence (A) on the 3? side of the target nucleic acid sequence. The second primer 1R includes, on the 3? side thereof, a sequence (B?) that can hybridize to a sequence (B) on the 3? side of either a strand extended from the first primer or a complementary strand of the target nucleic acid sequence 4. The first primer 1F and the second primer 1R include, on the 5? sides thereof, sequences (C) that are substantially identical to each other.
    Type: Application
    Filed: September 7, 2012
    Publication date: October 2, 2014
    Applicants: KABUSHIKI KAISHA DNAFORM, RIKEN
    Inventors: Yoshihide Hayashizaki, Yasumasa Kimura, Kengo Usui, Yuki Tanaka, Yuki Kawai
  • Publication number: 20130302783
    Abstract: The present invention is to provide a pretreatment method that allows RNA to be detected promptly and simply. RNA degradation activity due to lactoferrin present in the human rhinal mucosa is inhibited, for example, by adding iron ion and carbonate ion to a biological sample that contains the human rhinal mucosa. With the pretreated biological sample, an RNA virus gene can be amplified by a reverse transcriptase. Iron ion and carbonate ion can also inhibit reverse transcriptase inhibition due to lysozyme C contained in the human rhinal mucosa. Further, it is preferable to remove the envelope of the RNA virus by adding SDS to the biological sample that contains the human rhinal mucosa.
    Type: Application
    Filed: June 28, 2012
    Publication date: November 14, 2013
    Applicant: KABUSHIKI KAISHA DNAFORM
    Inventors: Yoshihide Hayashizaki, Kengo Usui, Saori Goda, Kazuhito Nomura, Yuki Kawai
  • Publication number: 20110236900
    Abstract: A method for determining the presence or absence of a mutation on the basis of the presence or absence of amplification with high reliability is provided. A target sequence including a target site contained in a sample nucleic acid is amplified using a primer that can hybridize to a region including the target site contained in the sample nucleic acid in the presence of a novel MutS having an amino acid sequence of SEQ ID NO: 2, and then the presence or absence of a mutation at the target site is determined on the basis of the presence or absence of amplification. The novel MutS binds more specifically to a mismatched base pair than to a fully-matched base pair, whereby an extension reaction caused by a mismatch-binding primer is suppressed. Thus, according to the present invention, the presence or absence of a mutation can be determined with high reliability.
    Type: Application
    Filed: November 27, 2009
    Publication date: September 29, 2011
    Applicants: RIKEN, KABUSHIKI KAISHA DNAFORM
    Inventors: Yoshihide Hayashizaki, Masayoshi Itoh, Hajime Kanamori, Kengo Usui, Kazuhito Nomura